STK11 and neoplasm: This approach has recently been demonstrated in the pancreas, where CRISPR-mediated targeting of liver kinase B1 (Lkb1) in mice led to tumour growth in conjunction with oncogenic Kras, phenocopying the effect of genetic deletion of Lkb1 (Chiou et al., 2015).